Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation
about
Identification of potential target genes for RFX4_v3, a transcription factor critical for brain developmentTherapeutic potential of perineural invasion, hypoxia and desmoplasia in pancreatic cancerInterferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survivalThe transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivoCX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin.The crystal structure of the chemokine domain of fractalkine shows a novel quaternary arrangementIntegrins αvβ3 and α4β1 act as coreceptors for fractalkine, and the integrin-binding defective mutant of fractalkine is an antagonist of CX3CR1Fractalkine, a CX3C chemokine, is expressed by dendritic cells and is up-regulated upon dendritic cell maturationCX3CR1 tyrosine sulfation enhances fractalkine-induced cell adhesionIdentification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejectionMutational analysis of the fractalkine chemokine domain. Basic amino acid residues differentially contribute to CX3CR1 binding, signaling, and cell adhesionRole for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microgliaHypoxia-induced astrocytes promote the migration of neural progenitor cells via vascular endothelial factor, stem cell factor, stromal-derived factor-1alpha and monocyte chemoattractant protein-1 upregulation in vitroMolecular cloning, functional characterization and mRNA expression analysis of the murine chemokine receptor CCR6 and its specific ligand MIP-3alphaAnalysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertionAnalysis of the Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Traumatic Brain and Spinal Cord Injury: Insight into Recent Advances in Actions of Neurochemokine Agents.Fractalkine Signaling Regulates Macrophage Recruitment into the Cochlea and Promotes the Survival of Spiral Ganglion Neurons after Selective Hair Cell LesionNext-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trials.The chemokine fractalkine can activate integrins without CX3CR1 through direct binding to a ligand-binding site distinct from the classical RGD-binding site.Differential ligand binding to a human cytomegalovirus chemokine receptor determines cell type-specific motility.Chorioamnionitis (ChA) modifies CX3CL1 (fractalkine) production by human amniotic epithelial cells (HAEC) under normoxic and hypoxic conditionsSpliced mRNA encoding the murine cytomegalovirus chemokine homolog predicts a beta chemokine of novel structureChemokines and chemokine receptors in infectious diseases.Interactions between chemokines: regulation of fractalkine/CX3CL1 homeostasis by SDF/CXCL12 in cortical neurons.High Glucose Level Disturbs the Resveratrol-Evoked Curtailment of CX3CL1/CX3CR1 Signaling in Human Placental CirculationHuman cytomegalovirus chemokine receptor gene US28 is transcribed in latently infected THP-1 monocytes.Generation and analysis of mice lacking the chemokine fractalkineLocal production of chemokines during experimental vaginal candidiasisInvolvement of fractalkine/CX3CL1 expression by dendritic cells in the enhancement of host immunity against Legionella pneumophila.Protracted downregulation of CX3CR1 on microglia of aged mice after lipopolysaccharide challengeCX3CL1 (fractalkine) protein expression in normal and degenerating mouse retina: in vivo studies.Hypoxia-inducible factor-1α regulates chemotactic migration of pancreatic ductal adenocarcinoma cells through directly transactivating the CX3CR1 gene.Fractalkine receptor (CX3CR1) deficiency sensitizes mice to the behavioral changes induced by lipopolysaccharideFractalkine attenuates excito-neurotoxicity via microglial clearance of damaged neurons and antioxidant enzyme heme oxygenase-1 expressionChemokines in tumor angiogenesis and metastasisCX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease.Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis.Interleukin-2/interleukin-2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation.
P2860
Q24299188-FEBE09F6-95A7-4910-AB5D-7FE91A24E321Q24621214-F8708E15-8F55-43FA-80CC-2DB84C41EFDDQ24647146-A7AA177A-6393-49E4-9F55-3A229C575743Q24676224-FE393D3F-809D-4261-BC2E-8F021DB993DAQ24685876-76054931-363E-4AB1-A495-657D3FAD2686Q24814510-43C71875-ADE8-412B-B2F5-4A42B9806BC6Q27622258-426ED8F2-B1BF-443B-AC2E-AAA627B37605Q28119172-798451CA-829B-4CCA-972E-15785A218391Q28142813-FB0C7F36-4CA9-4231-9F5C-4873B8F81E2BQ28209329-B8A9EBE4-7D57-40BF-9C02-0AE1B1868D2DQ28281345-827435F9-6AA4-43C3-B795-3BA3A4A40015Q28349698-C51C10AD-2E16-4070-A9CA-CE2F5B65D1CDQ28570617-F4811D61-4FCA-451C-AF5B-F4F23BBF22B3Q28573077-55A4817D-17F6-4BF8-B1A4-C5A1D8630C09Q28577073-8B8260FF-5A53-46F3-9721-D3593ED841AAQ28590941-A7D4A111-47DC-4178-92A0-8EB3AD002EFFQ29618089-E2FE6F1B-DC34-46A2-9136-2DF3D98AA930Q30360306-E7172EBC-AFB0-47E4-9E58-690935E0E196Q30383885-3D528DF1-097E-4236-8FA9-D6013276105FQ30578913-40CDF39B-0E07-47BC-BDA2-52946670CC51Q31160040-24B94032-A17A-475E-9CDD-5429F012863EQ33410786-DCB2A807-1EC4-40AF-8244-6C758360534AQ33645763-567D0C72-7C96-4DC9-B0C1-F11ADB78D139Q33646286-C4C17668-77A9-4D81-A6A6-31267EA4904EQ33778832-D83376F7-2371-4E03-811C-AE64D116FED7Q33796131-9EE3C17E-76DC-4CFA-8887-14144A085A5EQ33800749-953AAEC0-E550-4A39-8DC2-F6233C6B7E1AQ33842393-DA1ABF0D-7147-406C-B802-1BF0FE5D840AQ33941435-6CD6E55C-0D4D-4B24-B2DC-55E57B4DCAB7Q34002426-4EF69CD5-8946-4C33-92E2-F50AD94E8123Q34033832-3809C4DC-F6A3-4CE2-BF24-85EB9DA8A5BBQ34127089-85A66FFE-2915-40F1-802D-60100ED51CFDQ34142149-64F3D074-135F-4C44-9BB0-64FF9AA4F98FQ34405141-825CF734-6F77-43BA-B5BD-703342DA57B3Q34478106-AE474649-4528-4B11-96A9-A2D839ECD4A3Q34503290-B3864EA2-F5E0-4F4E-A111-F9E40CD751A7Q34540743-BB864CE1-A75F-4AA0-9A32-24DF2BE9EA99Q34576624-2FDA8BEF-9A45-4E29-BD8E-05F21603DAD8Q34828549-DCF4CAA7-A555-42ED-872F-0093FE9E20E8Q34861084-EBB53E2F-63FA-439D-868F-4698D873605F
P2860
Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation
@ast
Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation
@en
Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation
@nl
type
label
Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation
@ast
Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation
@en
Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation
@nl
prefLabel
Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation
@ast
Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation
@en
Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation
@nl
P2093
P921
P3181
P356
P1433
P1476
Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation
@en
P2093
B Dussault
J A Gonzalo
J C Gutierrez-Ramos
J Culpepper
P2888
P304
P3181
P356
10.1038/42491
P407
P577
1997-06-01T00:00:00Z
P6179
1000312641